Podlesak Dennis sold SNDX
October 29, 2026 · Form 4 insider transaction
Podlesak Dennis sold 8,000 shares of Syndax Pharmaceuticals, Inc. at $14.21 per share, a transaction worth $113.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person solely covering equity grants with expiration dates prior to Octobre 31, 2026. Following the sales reported in this Form 4, the Reporting Person has a total of 127,000 options to purchase shares of common stock that are vested and immediately exercisable and no unvested options to purchase shares of common stock.; The sale prices ranged from $14.00 to $14.59.